AI assistant
Sending…
PAVmed Inc. — Director's Dealing 2016
May 3, 2016
35221_dirs_2016-05-02_d5f3ccbd-010e-4945-bd7c-9ed352766cfa.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PAVmed Inc. (PAVM)
CIK: 0001624326
Period of Report: 2016-04-28
Reporting Person: Glennon Michael J (Director, Vice Chairman)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-04-28 | Employee Stock Option (Right to Buy) | $5.00 | A | 278726 | Acquired | 2026-04-28 | Common Stock (278726) | Direct |
Footnotes
F1: The option vests as to 3/36 of the shares on July 28, 2016 and in 33 equal monthly installments thereafter.
More from PAVmed Inc.
Earnings Release
2026
May 15
Interim / Quarterly Report
2026
May 14
Proxy Solicitation & Information Statement
2026
May 1
Annual Report
2026
Apr 30
Earnings Release
2026
Mar 30
Annual Report
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Feb 24
Regulatory Filings
2026
Feb 17
Capital/Financing Update
2026
Feb 4
Regulatory Filings
2026
Jan 23